![Phillip Koo, MD Profile](https://pbs.twimg.com/profile_images/923641291279179776/WzBQqBqw_x96.jpg)
Phillip Koo, MD
@PhillipKooMD
Followers
424
Following
623
Statuses
145
GU Nuclear Radiology/Chief of Diagnostic Imaging and Physician Executive, Banner MD Anderson/Views are my own
Phoenix, AZ
Joined August 2017
RT @apolo_andrea: 📣 Last call! Deadline extended to 12/15/24 Calling all #GU junior faculty & fellows! Apply today for the 2025 GU Ear…
0
10
0
RT @apolo_andrea: Calling GU junior faculty & fellows! 📣 Apply for the 2025 GU Early Career Thought Leaders conference in Philadelphia 3/6-…
0
28
0
@AlanBryce9 Amazing work and leadership @AlanBryce9. Looking forward to the 2025 meeting in CO. Much to discuss and debate
0
0
2
RT @AlanBryce9: Very happy to share the manuscript from the 2024 United States Prostate Cancer Consensus Conference. Our goal with this is…
0
28
0
RT @urotoday: 🚀 Exciting Opportunity! Applications are open for the GU Oncology Early Career Thought Leaders Conference, March 6-8, 2025, i…
0
5
0
Always a pleasure to speak w @thomashopemd who provides wonderful insights into some of the challenging scenarios w 177Lu PSMA 617. Congratulations on this important manuscript.
@SNM_MI consensus statement on patient selection and appropriate use of 177Lu-PSMA-617 radionuclide therapy. @thomashopemd @UCSF and @PhillipKooMD @BannerHealth discuss the @JournalofNucMed published statement in this conversation on UroToday >
0
0
9
Less than one month before our 4th Therapeutics Conference featuring a multi disciplinary group of faculty, hands on dosimetry sessions, discussions about operations, and our dynamic mock tumor boards. Come join us!
Today is the last day to take advantage of the extended early bird discount when you register to attend the 2023 SNMMI Therapeutics Conference, September 21-23, 2023, at the Marriott Baltimore Waterfront. Register by midnight at
0
2
9
@thomashopemd @SNM_MI @DrScottTagawa @EAntonarakis @lisabodei @CalaisJeremie @DrAIravani @HJacene @CaPsurvivorship @JOsbMD @morr316 Special kudos and thanks to @thomashopemd for leading this effort and getting the manuscript to the finish line in record time. Great content and will continue to evolve.
0
2
9
Future identity for nuc med physicians: “I am a trialist” Great vision set forth by @thomashopemd at the @SNM_MI therapeutics conference
0
1
16
Packed house as we kick off the 3rd @SNM_MI Therapeutics Conference. Billing/coding, operational, radiopharm supply, and disease specific sessions featuring mock tumor boards. #multid @tomboike @thomashopemd
2
1
18
@PBarataMD @ThePCCTC @ZEROCancer @PCFnews @urotoday @MCCRCHopeLives @NovartisCancer Thank you @PBarataMD for serving as an amazing host. What a wonderful evening in the Rex room @AntoinesNOLA with old and and new friends. Great learning more about Nola history from Oliver. @urotoday
0
0
5
@sartor_oliver top foodie picks for #AUA2022 in New Orleans. Some classics and hidden gems. Hungry anyone? @AmerUrological via @urotoday
0
0
0
RT @urotoday: @FDAOncology approves #Pluvicto for #mCRPC! #ReadNow details on UroToday > @charlesryanmd @WallisCJD…
0
3
0
@CathyRusGil @DrMHofman @JournalofNucMed I’m his doppelgänger. Not bad to be mistaken for someone with such deep knowledge and experience in this space.
1
0
0
RT @JournalofNucMed: Great news! CMS has granted Transitional Pass-Through Payment Status for PYLARIFY® (piflufolastat F 18) injection effe…
0
4
0